(Q37803219)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20977305%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Potential of St John's Wort for the treatment of depression: the economic perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20977305%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20977305%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Nicholas Graves

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20977305%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Daniela Solomon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20977305%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Emily Ford

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20977305%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

26 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20977305%20AND%20SRC:MED&resulttype=core&format=json

Australian and New Zealand Journal of Psychiatry

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20977305%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20977305%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20977305%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

123-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20977305%20AND%20SRC:MED&resulttype=core&format=json

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Complementary therapies for depression: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primar

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Capturing the value of complementary and alternative medicine: including patient preferences in economic evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Cost of treatment failure for major depression: direct costs of continued treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Unconventional medicine in the United States. Prevalence, costs, and patterns of use

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Use of antidepressants and complementary and alternative medicine among outpatients with depression in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

The use of complementary and alternative therapies to treat anxiety and depression in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Herbal remedies in psychiatric practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Antidepressant drug effects and depression severity: a patient-level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

A Descriptive Analysis of Minor Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Effectiveness gaps: a new concept for evaluating health service and research needs applied to complementary and alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Location bias in controlled clinical trials of complementary/alternative therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Hypericum and nurses: a comprehensive literature review on the efficacy of St. John's Wort in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

St. John's wort - an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Mechanism of action of St John's wort in depression : what is known?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Role of hyperforin in the pharmacological activities of St. John's Wort.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

St John's wort for depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

St. John's wort and the treatment of mild to moderate depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Is infestation with the common bedbug increasing?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Herbal medicines in the treatment of psychiatric disorders: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Adverse Effects of St. John’s Wort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Interactions between herbal medicines and prescribed drugs: an updated systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Hyperforin in St. John's wort drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Evaluating the economic consequences of early antidepressant treatment discontinuation: a comparison between controlled-release and immediate-release paroxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

St. John's wort for depression: a meta-analysis of well-defined clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Large-scale observational studies of hypericum extracts in patients with depressive disorders--a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Safety of St. John's Wort extract compared to synthetic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

The impact of patient participation on adherence and clinical outcome in primary care of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Patients' preferences in the treatment of depressive disorder in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Issues in the dissemination of cognitive-behavior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Economic evaluation of online computerised cognitive-behavioural therapy without support for depression in primary care: randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

STAR*D: has it taught us anything about the management of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094

Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048674.2010.526094